The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis (ALS) patients, who have lost natural speech ...

Alex Knapp is a Forbes senior editor covering healthcare and science.

A non-invasive and artificial intelligence (AI) powered brain-computer interface (BCI) device developed by US-based startup Cognixion has now entered a crucial patient trial. Ten patients with ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most patients reach a point at which either the disease itself or a necessary ...